Low bone mass in patients with motor disability: Prevalence and risk factors in 59 Finnish children

Developmental Medicine and Child Neurology

Volumn 52, Issue 3, 2010, Pages 276-282

  Kilpinen Loisa, Päivi ^a   Paasio, Taava ^a   Soiva, Martti ^a   Ritanen, Ulla Maija ^a   Lautala, Pentti ^a   Palmu, Petri ^b   Pihko, Helena ^b   Mäkitie, Outi ^b  

^a PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CALCIUM; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; VITAMIN D;

ADOLESCENT; ARTICLE; BLOOD CHEMISTRY; BODY MASS; BONE DENSITY; BONE DISEASE; BONE MASS; CALCIUM HOMEOSTASIS; CALCIUM INTAKE; CEREBRAL PALSY; CHILD; CHROMOSOME ABERRATION; COHORT ANALYSIS; COMPRESSION FRACTURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; DUCHENNE MUSCULAR DYSTROPHY; EPILEPSY; FEMALE; FRACTURE; HUMAN; HYPERCALCIURIA; LEG FRACTURE; MAJOR CLINICAL STUDY; MALE; MENINGOMYELOCELE; MORPHOLOGY; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; ORGAN SIZE; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SPINAL MUSCULAR ATROPHY; SPINE RADIOGRAPHY; VITAMIN BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; BONE DENSITY; BONE DISEASES; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; FINLAND; FRACTURES, BONE; HUMANS; HYPERCALCIURIA; MALE; MOVEMENT DISORDERS; OSTEOPOROSIS; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; VITAMIN D DEFICIENCY;

EID: 76349124220     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2009.03464.x     Document Type: Article

References (38)

1. van der Sluis IM, de Muinck Keizer-Schrama SM. Osteoporosis in childhood: bone density of children in health and disease. J Pediatr Endocrinol Metab 2001, 14:817-32.
2. Henderson RC, Lark RK, Gurka MJ. Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics 2002, 110(1Pt 1).
3. King W, Levin R, Schmidt R, Oestreich A, Heubi J. Prevalence of reduced bone mass in children and adults with spastic quadriplegia. Dev Med Child Neurol 2003, 45:12-6.
4. Henderson RC. Bone density and other possible predictors of fracture risk in children and adolescents with spastic quadriplegia. Dev Med Child Neurol 1997, 39:224-7.
5. Kilpinen-Loisa P, Nenonen H, Pihko H, Mäkitie O. High-dose vitamin D supplementation in children with cerebral palsy or neuromuscular disorder. Neuropediatrics 2007, 38:167-72.
6. Fitzpatrick L. Pathophysiology of bone loss in patients receiving anticonvulsant therapy. Epilepsy Behav 2004, 5:S3-15.
7. Sorva R, Lankinen S, Tolppanen EM, Perheentupa J. Variation of growth in height and weight of children. II. After infancy. Acta Paediatr Scand 1990, 79:498-506.
8. National Nutrition Council, Nutrition Recommendation Section, Ministry of Agriculture and Forestry, Helsinki, Finland. 2005, http://www.mmm.fi/ravitsemusneuvottelukunta, (accessed 5 November 2007)
9. van der Sluis IM, de Ridder MA, Boot AM, Krenning EP, de Muinck Keizer-Schrama SM. Reference data for bone density and body composition measured with dual energy X-ray absorptiometry in white children and young adults. Arch Dis Child 2002, 87:341-7.
10. Kröger H, Kotaniemi A, Kröger L, Alhava E. Development of bone mass and bone density of the spine and femoral neck - a prospective study of 65 children and adolescents. Bone Miner 1993, 23:171-82.
11. Greulich WW, Pyle SI. Radiographic Atlas of the Skeletal Development of the Hand and Wrist 1959, 2nd edn, Palo Alto, CA, Stanford University Press
12. Mäkitie O, Doria AS, Henriques F. Radiographic vertebral morphology: a diagnostic tool in pediatric osteoporosis. J Pediatr 2005, 146:395-401.
13. Misra M, Pacaud D, Petryk A, Collet-Solberg PF, Kappy M. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008, 122:398-417.
14. Agresti A. Categorical Data Analysis 2002, New Jersey, John Wiley
15. Efron B, Tibshirani RJ. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Statist Sci 1986, 1:54-77.
16. Rauch F, Plotkin H, DiMeglio L. Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 pediatric official positions. J Clin Densitom 2008, 11:22-8.
17. McDonald DG, Kinali M, Gallagher AC. Fracture prevalence in Duchenne muscular dystrophy. Dev Med Child Neurol 2002, 44:695-98.
18. Larson CM, Henderson RC. Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J Pediatr Orthop 2000, 20:71-4.
19. Cheng JC, Shen WY. Limb fracture pattern in different pediatric age groups: a study of 3350 children. J Orthop Trauma 1993, 7:15-22.
20. Stevenson RD, Conaway M, Barrington JW, Cuthill SL, Worley G, Henderson RC. Fracture rate in children with cerebral palsy. Pediatr Rehabil 2006, 9:396-403.
21. Valta H, Lahdenne P, Jalanko H, Aalto K, Mäkitie O. Bone health and growth in patients with juvenile idiopathic arthritis. J Rheumatol 2007, 34:831-6.
22. Valta H, Jalanko H, Holmberg C, Helenius I, Mäkitie O. Impaired bone health in adolescents after liver transplantation. Am J Transplant 2008, 8:150-7.
23. Taskinen M, Saarinen-Pihkala UM, Hovi L, Vettenranta K, Mäkitie O. Bone health in children and adolescents after allogeneic stem cell transplantation: high prevalence of vertebral compression fractures. Cancer 2007, 110:442-51.
24. King WM, Ruttencutter R, Nagaraja HN. Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy. Neurology 2007, 68:1607-13.
25. Gordon C, Bachrach L, Carpenter T. Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD pediatric official positions. J Clin Densitom 2008, 11:43-58.
26. Harcke HT, Taylor A, Bachrach S, Miller F, Henderson RC. Lateral femoral scan: an alternative method for assessing bone mineral density in children with cerebral palsy. Pediatr Radiol 1998, 28:241-6.
27. Samson-Fang L, Stevenson RD. Linear growth velocity in children with cerebral palsy. Dev Med Child Neurol 1998, 40:689-92.
28. Worley G, Houlihan CM, Herman-Giddens ME. Secondary sexual characteristics in children with cerebral palsy and moderate to severe motor impairment: a cross-sectional survey. Pediatrics 2002, 110:897-902.
29. Henderson RC, Gilbert SR, Clement ME, Abbas A, Worley G, Stevenson RD. Altered skeletal maturation in moderate to severe cerebral palsy. Dev Med Child Neurol 2005, 47:229-36.
30. Gafni R, Baron J. Overdiagnosis of osteoporosis in children due to misinterpretation of dual-energy X-ray absorptiometry (DEXA). J Pediatr 2004, 144:253-7.
31. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005, 16:713-6.
32. Mantel N. Why step down procedures in variable selection. Technometrics 1970, 12:621-5.
33. Miller AJ. Selection of subsets of regression variables. J R Stat Soc A 1984, 147:389-425.
34. Murray GD. A cautionary note on selection of variables in discriminant analysis. Appl Stat 1977, 26:246-50.
35. Copas JB. Regression, prediction and shrinkage. J R Stat Soc A 1983, 145:311-54.
36. Bishop N, Braillon P, Burnham J. Dual energy x-ray absorptiometry assessment in children and adolescents with disease that may affect skeleton: the 2007 ISCD Pediatric Official Positions. J Clin Densitom 2008, 11:29-42.
37. Plotkin H, Coughlin S, Kreikemeier R, Heldt K, Bruzoni M, Lerner G. Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study. Dev Med Child Neurol 2006, 48:709-12.
38. Bachrach LK, Ward LM. Clinical review 1. Bisphosphonate use in childhood osteoporosis. J Clin Endocrinol Metab 2009, 94:400-9.